Abstract
A 43-year-old patient developed factor V inhibitor 6 months after liver transplantation for primary biliary cirrhosis in association with Sjögren's syndrome/systemic lupus erythematosus. She suffered from ecchymoses in the lower extremities. The factor V inhibitor was eradicated after 10 weekly doses of 375-500 mg/m2 rituximab.
Original language | English (US) |
---|---|
Pages (from-to) | 363-365 |
Number of pages | 3 |
Journal | American Journal of Hematology |
Volume | 77 |
Issue number | 4 |
DOIs | |
State | Published - Dec 2004 |
Keywords
- Factor V inhibitor
- Primary biliary cirrhosis
- Rituximab
- Sjögren's syndrome
- Systemic lupus erythematosus
ASJC Scopus subject areas
- Hematology